Panel 2:  Biotech & Healthcare

MAR 20, 8:30 PM EDT  //  MAR 21, 8:30 AM BJT

Dr. Linfa Wang

Professor in the Programmme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore.

Prof Wang currently serves on the WHO’s International Health Regulations Emergency Committee to discuss and provide his expertise for the ongoing COVID-19 outbreak.


Dr. Yi Shi

Founder & Managing Partner of
Lilly Asia Ventures

Yi Shi is the Founder and Managing Partner of Lilly Asia Ventures, a biomedical venture capital firm with focus on China and cross-border opportunities. Prior to his current role, Yi worked at Eli Lilly and Company in business development licensing and corporate ventures. His education includes a Ph.D. in Biochemistry and a Master of Business Administration, both from Duke University.


Yuanchao Xie

Marketing manager at Amgen-BeiGene

Yuanchao Xie is a marketing manager at Amgen. He currently works at the global marketing function to support oncology product launch in China. Prior to this role, He works in US Value Strategy & Marketing as a marketing manager with focus in in-line oncology products.